Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1Breast 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Myofibroma 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 10pembrolizumab 9Cyclophosphamide 9Flow Cytometry 7sargramostim 6Therapeutics 6Taxes 5Polymerase Chain Reaction 5Immunoenzyme Techniques 5Docetaxel 5Carboplatin 5aldesleukin 4Psychiatric Rehabilitation 4Fulvestrant 4Filgrastim 4ribociclib 3Trastuzumab 3Radiotherapy 3Peripheral Blood Stem Cell Transplantation 3Nivolumab 3Mass Spectrometry 3Interleukin-12 Subunit p35 3Immunologic Techniques 3Immunohistochemistry 3Gene Expression Profiling 3Amplified Fragment Length Polymorphism Analysis 3Amifostine 3talazoparib 2spartalizumab 2sacituzumab govitecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × Hysterectomy × Breast × Clear all
NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern University

Recruiting
6,000 enrolled
BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡